Clinical Trial Update: Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 feasibility trial evaluating human umbilical cord tissue-derived mesenchymal stem cells in patients with multiple sclerosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Translational Biosciences | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED